Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. November 2025 10:21 ET | Quelle: Research and Markets

Essential Thrombocythemia Global Market Analysis and Forecast, 2025-2035 - Innovative Research in Gene Therapies Paves New Pathways for ET Management

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Essential Thrombocythemia Market - A Global and Regional Analysis: Focus on Drug Class, Route of Administration, and Region - Analysis and Forecast,...
18. November 2025 10:23 ET | Quelle: Research and Markets

Myelofibrosis Market Research 2025-2035: Novel BET, BCL-2, and CDK Inhibitors Drive Strong Growth Opportunities as Personalized and Genomic-Based Therapies Reshape the Expanding Landscape

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Myelofibrosis Market - A Global and Regional Analysis: Focus on Therapy Type, Route of Administration, End User, Country, and Region - Analysis and...
24. Januar 2024 07:57 ET | Quelle: Research and Markets

JAKAFI (Ruxolitinib) Emerging Drug Insights and Market Forecasts, 2019-2032: Focus on 7MM - United States, Germany, France, Italy, Spain, United Kingdom, and Japan

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "JAKAFI Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides a detailed...
18. Juni 2021 07:53 ET | Quelle: Research and Markets

China Ruxolitinib Market Report 2021-2025: An Orally Bioavailable Janus-associated kinase (JAK) Inhibitor with Selectivity for Subtypes JAK1 and JAK2

Dublin, June 18, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Ruxolitinib Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Ruxolitinib was developed by...